EFFECTIVE HALF-LIFE OF I-131 IN THYROID CARCINOMA PATIENTS RECEIVING LOW-DOSE ABLATION THERAPY WITH RTSH

被引：0
|
作者：
Willowson, K. [1 ]
Bailey, D. [2 ]
Forwood, N. [2 ]
Bailey, E. [2 ]
Roach, P. [2 ]
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Royal N Shore Hosp, Dept Nucl Med, Sydney, NSW, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2012年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [31] Thyroid remnant I-131 ablation for papillary and follicular thyroid carcinoma
    Mazzaferri, EL
    THYROID, 1997, 7 (02) : 265 - 271
  • [32] EFFECTIVE HALF-LIFE IN RADIOIODINE THERAPY OF THYROID
    HLISCS, R
    HENNIG, K
    RADIOLOGIA DIAGNOSTICA, 1978, 19 (01) : 92 - 92
  • [33] THERMOLUMINESCENT METHOD FOR ESTIMATION OF EFFECTIVE THYROIDAL HALF-LIFE OF THERAPEUTIC I-131 IN TOXIC GOITER
    MALONE, JF
    CULLEN, MJ
    BRITISH JOURNAL OF RADIOLOGY, 1975, 48 (573): : 762 - 764
  • [34] RhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of 131I
    Menzel, C
    Kranert, WT
    Döbert, N
    Diehl, M
    Fietz, T
    Hamscho, N
    Berner, U
    Grünwald, F
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (07) : 1065 - 1068
  • [35] Low versus High I-131 Dose for Remnant Ablation in Differentiated Thyroid Cancer
    Hackshaw, Allan
    Mallick, Ujjal
    CLINICAL MEDICINE & RESEARCH, 2009, 7 (1-2) : 1 - 1
  • [36] Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
    Kobe, Carsten
    Eschner, Wolfgang
    Wild, Markus
    Rahlff, Ilka
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Dietlein, Markus
    Schicha, Harald
    NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (03) : 201 - 205
  • [37] Ablation efficacy for non-distant metastases differentiated thyroid carcinoma with low-dose （131）I
    郑立春
    China Medical Abstracts(Internal Medicine), 2018, 35 (02) : 82 - 83
  • [38] Effectiveness of low dose Iodine 123 (I-123) in evaluation of patients with differential thyroid carcinoma before therapy with Iodine 131 (I-131).
    Vlachou, F.
    Gogou, L.
    Gogos, K.
    Dalianis, K.
    Tsilomeleti, I.
    Merisoglou, S.
    Tsiakas, E.
    Papoutsani, D.
    Plataniotis, N.
    Prassopoulos, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S265 - S265
  • [39] HALF-LIFE OF I-131 INSULIN IN DIFFERENT GROUPS OF PATIENTS COMPARED WITH NORMAL SUBJECTS
    VANROOYEN, RJ
    HOOG, JMC
    BIELER, EU
    DEBRUIN, EJP
    SOUTH AFRICAN MEDICAL JOURNAL, 1972, 46 (49): : 1927 - +
  • [40] EFFECTS OF I-131 ABLATION OF THYROID REMNANTS AND I-131-THERAPY OF METASTASES ON SERUM THYROGLOBULIN LEVELS IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA
    SANGUINETI, M
    RANDAZZO, M
    CANEVAROLLO, N
    BERTOLAZZI, L
    ZINO, V
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1983, 27 (02): : 188 - 189
12345